Researchers identify the elusive antibody that zaps resilient dengue serotype 2.

A research team from Duke-NUS, Vanderbilt University, the University of North Carolina and the University of California, Berkeley has found the second-to-last piece of the puzzle needed to potentially cure or treat dengue. This is welcome news as the dengue virus infects about 400 million people worldwide annually, and there is currently no licensed vaccine available to treat it.  The new study showed how an antibody … Continue reading Researchers identify the elusive antibody that zaps resilient dengue serotype 2.